Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea

BackgroundHeart failure with reduced ejection fraction (HFrEF) is a clinical condition frequently diagnosed in clinical practice. In patients affected by HFrEF, sleep apnea (SA) can be detected among the most frequent comorbidities. Sacubitril–valsartan (sac/val) association has been proven to be ef...

Full description

Bibliographic Details
Main Authors: Corrado Pelaia, Giuseppe Armentaro, Mara Volpentesta, Luana Mancuso, Sofia Miceli, Benedetto Caroleo, Maria Perticone, Raffaele Maio, Franco Arturi, Egidio Imbalzano, Francesco Andreozzi, Francesco Perticone, Giorgio Sesti, Angela Sciacqua
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.861663/full

Similar Items